Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrkla A Regulatory News (0FIN)

Share Price Information for Orkla A (0FIN)

Share Price is delayed by 15 minutes
Get Live Data
101.30    1.00 (1.00%)
Bid:
99.20
Ask:
103.40
Spread: 4.20 (4.234%)
Market Cap:
0FIN Live PriceLast checked at - London Stock Exchange

Intraday Orkla A Share Chart

  • This share is an international stock.

Orkla ASA: Status share buy-back programme

4 Feb 2026 07:00

Transactions made under the buy-back programme for Orkla ASA

Date on which the buy-back programme was announced: 14 November 2025

The duration of the buy-back programme: 31 December 2026

Overview of transactions:

DateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)
28/01/2026320,000112.550136,016,032
29/01/2026320,000113.302536,256,800
30/01/2026320,000114.155336,529,696
02/02/2026320,000114.869536,758,240
03/02/2026278,143114.902931,959,437
Previously disclosed buybacks under the programme (accumulated)14,442,883110.46831,595,480,256
Accumulated under the buyback programme16,001,026110.80541,773,000,462

The issuer's holding of own shares: Following the completion of the above transactions, Orkla ASA owns a total of 19,888,418 of own shares, corresponding to 1.99% of Orkla ASA's share capital.

Appendix: An overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this stock exchange announcement and available at www.newsweb.no.

Ref.:Investor Relations ManagerOle Andreas Steensland DahlMail: oasd@orkla.noMob.: +47 907 07 937

This is information that Orkla ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

AttachmentsOrkla ASA Transactions 28 01 2026 03 02 2026

12
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.